1. Heparanase: Cloning, Function and Regulation
   Shaun M. Gaskin et al, 2020, Heparanase CrossRef
2. Silibinin suppresses epithelial–mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1
   Suyan Xu et al, 2020, Cellular & Molecular Biology Letters CrossRef
3. Inhibition of Cot1/Tlp2 oncogene in AML cells reduces ERK5 activation and upregulates p27Kip1concomitant with enhancement of differentiation and cell cycle arrest induced by silibinin and 1,25-dihydroxyvitamin D3
   Xuening Wang et al, 2010, Cell Cycle CrossRef
4. IGF-1R/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations
   Alejandro Vazquez-Martin et al, 2013, Scientific Reports CrossRef
5. Heparanase is a host enzyme required for herpes simplex virus-1 release from cells
   Satvik R. Hadigal et al, 2015, Nature Communications CrossRef
6. Ougan (Citrus reticulata cv. Suavissima) flavedo extract suppresses cancer motility by interfering with epithelial-to-mesenchymal transition in SKOV3 cells
   Linlin Chang et al, 2015, Chinese Medicine CrossRef
7. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial–mesenchymal transition and stemness
   Kaijie Wu et al, 2013, Cellular Signalling CrossRef
8. Glucose-regulated protein 78 and heparanase expression in oral squamous cell carcinoma: correlations and prognostic significance
   Fei Xia et al, 2014, World Journal of Surgical Oncology CrossRef
9. Role of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells
   Luis A Aparicio et al, 2014, BMC Cancer CrossRef
10. Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
    Jones T. Nauseef et al, 2011, Nature Reviews Urology CrossRef
11. Plumbagin induces ROS-mediated apoptosis and cell cycle arrest and inhibits EMT in human cervical carcinoma cells
    Ankita Jaiswal et al, 2018, RSC Advances CrossRef
12. IFITM protein regulation and functions: Far beyond the fight against viruses
    Nela Friedlová et al, 2022, Frontiers in Immunology CrossRef
13. Cancer chemoprevention through dietary flavonoids: what’s limiting?
    Haneen Amawi et al, 2017, Chinese Journal of Cancer CrossRef
14. An Overview of Anticancer Herbal Medicines
    Addanki P. Kumar et al, 2011, Evidence-based Anticancer Materia Medica CrossRef
15. Smad4 suppresses the tumorigenesis and aggressiveness of neuroblastoma through repressing the expression of heparanase
    Hongxia Qu et al, 2016, Scientific Reports CrossRef
16. A Promising CAM Therapeutic For Multiple Cancers: Milk Thistle (Silybum)
    Seema Patel, 2015, Emerging Bioresources with Nutraceutical and Pharmaceutical Prospects CrossRef
17. Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity
    Y Yang et al, 2015, Oncogene CrossRef
18. Novel Therapies for the Treatment of Advanced Prostate Cancer
    J. M. Clarke et al, 2013, Current Treatment Options in Oncology CrossRef
19. Metastasis: A Major Driver of Cancer Pathogenesis
    Pradeep Singh Cheema et al, 2020, Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models CrossRef
20. NF-κB signaling and crosstalk during carcinogenesis
    Björn L.D.M. Brücher et al, 2019, 4open CrossRef
21. Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo
    Sílvia Cufí et al, 2013, Scientific Reports CrossRef
22. Silibinin suppresses TGFβ2-induced lens epithelial cell migration and epithelial–mesenchymal transition
    Pooja B Malaviya et al, 2022, Journal of Biosciences CrossRef
23. Heparanase Upregulation Contributes to Porcine Reproductive and Respiratory Syndrome Virus Release
    Chunhe Guo et al, 2017, Journal of Virology CrossRef
24. PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription
    Kaijie Wu et al, 2012, Cellular Signalling CrossRef